AH ALEAFIA HEALTH INC

Aleafia Health: Invitation to the Benzinga Virtual Cannabis Capital Conference

Detroit, Michigan--(Newsfile Corp. - June 2, 2021) - Aleafia Health (TSX: AH) will be presenting at the Benzinga Cannabis Capital Conference taking place on June 3-4, 2021. We invite our shareholder and all interested parties to join us for a full day of networking, dealmaking and discovery. Sign up to get a free spectator pass for the event:

About Benzinga Cannabis Capital Conference

Benzinga's virtual Cannabis Capital Conference is guaranteed to offer participants all the benefits of an immersive and robust in-person conference from any remote location. The conference will feature an interactive forum of live presentations from top CEOs, investors, and leaders in the cannabis space. Don't miss this opportunity to connect with THE cannabis movers and shakers from across the globe.

For more information and/or to register for the conference please visit:

We look forward to seeing you there.

For further information:

Aleafia Health
Nicholas Bergamini
1-833-879-2533

EN
03/06/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on ALEAFIA HEALTH INC

 PRESS RELEASE

Aleafia Health Announces Successful Bids in Sale and Investment Solici...

Aleafia Health Announces Successful Bids in Sale and Investment Solicitation Process TORONTO, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (“Aleafia” or the “Corporation”) announces that Red White & Bloom Brands Inc. (“RWB”) has been selected as the successful bidder pursuant to the Court-approved sale and investment solicitation process (the “SISP”) in connection with the previously announced proceedings of Aleafia and certain of its subsidiaries under the Companies’ Creditors Arrangement Act (the “CCAA”). On August 22, 2023, the Ontario Superior Court of Justice (Commercial Li...

 PRESS RELEASE

Aleafia Health Obtains Creditor Protection to Pursue Restructuring and...

Aleafia Health Obtains Creditor Protection to Pursue Restructuring and Sale Process TORONTO, July 25, 2023 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX:AH, OTCQB:ALEAF) (“Aleafia” or the “Corporation”) announces today that the Corporation and certain of its Canadian subsidiaries, Emblem Corp., Emblem Cannabis Corporation, Emblem Realty Ltd., Growwise Health Limited, Canabo Medical Corporation, Aleafia Inc., Aleafia Farms Inc., Aleafia Brands Inc., Aleafia Retail Inc., 2672533 Ontario Inc., and 2676063 Ontario Inc. (collectively, the “Aleafia Group”) have been granted an order (the “Initia...

 PRESS RELEASE

Red White & Bloom and Aleafia Health Mutually Agree to Terminate Bindi...

Red White & Bloom and Aleafia Health Mutually Agree to Terminate Binding Letter Agreement TORONTO, July 14, 2023 (GLOBE NEWSWIRE) -- Red White & Bloom Brands Inc. (CSE: RWB and OTC: RWBYF) (“RWB” or the “Company”) and Aleafia Health Inc. (TSX: AH and OTCQB: ALEAF) (“Aleafia”) are announcing the mutual termination of the binding letter agreement entered into between the parties on June 6, 2023 (the “Letter Agreement”) in respect of the proposed business combination transaction (the “Proposed Transaction”), as detailed in the joint press release issued on June 7, 2023. The termination is wi...

 PRESS RELEASE

Aleafia Health Announces In-Kind Payment of Interest on Secured Conver...

Aleafia Health Announces In-Kind Payment of Interest on Secured Convertible Debentures TORONTO, June 22, 2023 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTCQB: ALEAF) (“Aleafia Health” or the “Company”) announces that it is electing to pay interest in-kind on its (a) 8.50% Series A Secured Debentures Due June 30, 2024 (the “Series A Debentures”), (b) 8.50% Series B Secured Debentures Due June 30, 2026 (the “Series B Debentures”), and (c) 8.50% Series C Secured Convertible Debentures Due June 30, 2028 (the “Series C Debentures” and, collectively with the Series A Debentures and the...

 PRESS RELEASE

Aleafia Health Announces Fourth Quarter and Annual Financial Results

Aleafia Health Announces Fourth Quarter and Annual Financial Results Revenue increased 9% to $11.7 million for the period ended March 31, 2023 (“Q4 FY2023”) versus $10.7 million for the period ended March 31, 2022 Net revenue increased 33% to $9.4 million for Q4 FY2023 versus $7.0 million for the period ended March 31, 2022Revenue increased 24% to $57.4 million for the 12 months ended March 31, 2023 (“FY2023”) over the twelve months ended March 31, 2022Net revenue increased 19% to $42.8 million for FY2023 over the twelve months ended March 31, 2022#5 and #2 market share ranking in Divvy pre...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch